ReviewFrontiers in immunology2021

Defects in Macrophage Reprogramming in Cancer Therapy: The Negative Impact of PD-L1/PD-1.

Hao Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.